Gossamer Bio Inc (GOSS) support and resistance · rev $114.7M
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
This page maps Gossamer Bio Inc (GOSS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GOSS revenue for 2024-12-31 was $114.7M. Net income was -$56.5M. GOSS currently screens at market cap $47.0M.
GOSS currently screens at market cap $47.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GOSS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GOSS quote page for the session range and the stock page for the full model.
Not investment advice.